title: Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.
authors.affiliation: Mayo Clinic Rochester, 200 First Street SW, Rochester, MN 55905, USA. sarkaria.jann@mayo.edu
authors.forename: Jann N
authors.initials: JN
authors.lastname: Sarkaria
authors.forename: Eva
authors.initials: E
authors.lastname: Galanis
authors.forename: Wenting
authors.initials: W
authors.lastname: Wu
authors.forename: Allan B
authors.initials: AB
authors.lastname: Dietz
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Kaufmann
authors.forename: Michael P
authors.initials: MP
authors.lastname: Gustafson
authors.forename: Paul D
authors.initials: PD
authors.lastname: Brown
authors.forename: Joon H
authors.initials: JH
authors.lastname: Uhm
authors.forename: Ravi D
authors.initials: RD
authors.lastname: Rao
authors.forename: Laurence
authors.initials: L
authors.lastname: Doyle
authors.forename: Caterina
authors.initials: C
authors.lastname: Giannini
authors.forename: Kurt A
authors.initials: KA
authors.lastname: Jaeckle
authors.forename: Jan C
authors.initials: JC
authors.lastname: Buckner